155 related articles for article (PubMed ID: 25129125)
1. CD44 expression in curettage and postoperative specimens of endometrial cancer.
Wojciechowski M; Krawczyk T; Śmigielski J; Malinowski A
Arch Gynecol Obstet; 2015 Feb; 291(2):383-90. PubMed ID: 25129125
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in papillary serous endometrial carcinoma.
Hosford S; Elliott J; Ma ZW; Majeste R; Dubeshter B
Int J Gynecol Cancer; 2003; 13(4):480-4. PubMed ID: 12911725
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.
Njølstad TS; Trovik J; Hveem TS; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; ; Amant F; Werner HM; Salvesen HB; Danielsen HE
Br J Cancer; 2015 May; 112(10):1656-64. PubMed ID: 25897678
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue.
Kansu-Celik H; Gungor M; Ortac F; Kankaya D; Ensari A
Arch Gynecol Obstet; 2017 Aug; 296(2):313-318. PubMed ID: 28620808
[TBL] [Abstract][Full Text] [Related]
6. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
7. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
8. The Role of CD44 and RHAMM in Endometrial (Endometrioid Type) Cancer: An Immunohistochemical Study.
Klarić M; Haller H; Brnčić Fischer A; Babarović E; Prijić A; Eminović S
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):606-612. PubMed ID: 29734248
[TBL] [Abstract][Full Text] [Related]
9. Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Trovik J; Wik E; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; Njolstad TS; ; Vandenput I; Amant F; Akslen LA; Salvesen HB
Clin Cancer Res; 2011 May; 17(10):3368-77. PubMed ID: 21242118
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.
Ayhan A; Tok EC; Bildirici I; Ayhan A
Gynecol Oncol; 2001 Mar; 80(3):355-8. PubMed ID: 11263931
[TBL] [Abstract][Full Text] [Related]
11. Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?
Gülseren V; Kocaer M; Özdemir İA; Çakır İ; Sancı M; Güngördük K
Curr Probl Cancer; 2020 Feb; 44(1):100498. PubMed ID: 31395281
[TBL] [Abstract][Full Text] [Related]
12. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy.
Bonfitto VL; de Angelo Andrade LA
Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509
[TBL] [Abstract][Full Text] [Related]
13. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma.
Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR
Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604
[TBL] [Abstract][Full Text] [Related]
14. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
16. CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.
Tokumo K; Kodama J; Seki N; Miyagi Y; Yoshinouchi M; Kudo T
Cancer Lett; 1998 Mar; 125(1-2):221-5. PubMed ID: 9566719
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cancer: can nodal status be predicted with curettage?
Mariani A; Sebo TJ; Katzmann JA; Roche PC; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2005 Mar; 96(3):594-600. PubMed ID: 15721399
[TBL] [Abstract][Full Text] [Related]
18. Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer.
Tanaka T; Terai Y; Ono YJ; Fujiwara S; Tanaka Y; Sasaki H; Tsunetoh S; Kanemura M; Yamamoto K; Yamada T; Ohmichi M
Int J Gynecol Cancer; 2015 Jun; 25(5):879-83. PubMed ID: 25950131
[TBL] [Abstract][Full Text] [Related]
19. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
